Localisation and physiological regulation of corticotrophin-releasing factor receptor 1 mRNA in the Xenopus laevis brain and pituitary gland

Journal of Neuroendocrinology

Volumn 18, Issue 10, 2006, Pages 797-805

  Calle, M ^a   Jenks, B G ^a   Corstens, G J H ^a   Veening, J G ^a,b   Barendregt, H P ^a   Roubos, Eric W ^a  

^a RADBOUD UNIVERSITY NIJMEGEN   (Netherlands)

^b UTRECHT UNIVERSITY   (Netherlands)

Author keywords

melanophore stimulating hormone; Corticotrophin releasing factor receptor 1; In situ hybridisation; Melanotroph cells; Urocortin; Xenopus laevis

Indexed keywords

ALPHA INTERMEDIN; CORTICOTROPIN RELEASING FACTOR; CORTICOTROPIN RELEASING FACTOR RECEPTOR 1; MESSENGER RNA; UNCLASSIFIED DRUG; UROCORTIN; UROCORTIN I;

AMYGDALOID NUCLEUS; ANIMAL TISSUE; ARTICLE; BINDING AFFINITY; BRAIN REGION; CEREBELLUM; CONTROLLED STUDY; GENE EXPRESSION REGULATION; GENE LOCATION; HABENULA; HORMONE RELEASE; HYPOPHYSIS; HYPOPHYSIS INTERMEDIATE LOBE; HYPOTHALAMUS; IN SITU HYBRIDIZATION; LIGHT INTENSITY; MAMMAL; MESENCEPHALON; NONHUMAN; NUCLEOTIDE SEQUENCE; NUCLEUS ACCUMBENS; OLFACTORY BULB; OPTICAL DENSITY; PREOPTIC AREA; PRIORITY JOURNAL; PULVINAR; RECEPTOR BINDING; SIGNAL TRANSDUCTION; SUPRACHIASMATIC NUCLEUS; THALAMUS VENTRAL NUCLEUS; XENOPUS LAEVIS;

ADAPTATION, PHYSIOLOGICAL; ANIMALS; BRAIN CHEMISTRY; CORTICOTROPIN-RELEASING HORMONE; IN SITU HYBRIDIZATION; LIGHTING; MELANINS; PITUITARY GLAND; RECEPTORS, CORTICOTROPIN-RELEASING HORMONE; RNA, MESSENGER; XENOPUS LAEVIS;

EID: 33748439370     PISSN: 09538194     EISSN: 13652826     Source Type: Journal    
DOI: 10.1111/j.1365-2826.2006.01475.x     Document Type: Article

References (50)

1. Vale WW, Spiess J, Rivier C, Rivier J. Characterization of a 41-residue ovine hypothalamic peptide that stimulates secretion of corticotropin and beta-endorphin. Science 1981; 213: 1394-1397.
2. Vaughan J, Donaldson C, Bittencourt J, Perrin MH, Lewis K, Sutton S, Chan R, Turnbull AV, Lovejoy D, Rivier C. Urocortin, a mammalian neuropeptide related to fish urotensin I and to corticotropin-releasing factor. Nature 1995; 378: 287-292.
3. Bittencourt JC, Vaughan J, Arias C, Rissman RA, Vale WW, Sawchenko PE. Urocortin expression in rat brain: Evidence against a pervasive relationship of urocortin-containing projections with targets bearing type 2 CRF receptors. J Comp Neurol 1999; 415: 285-312.
4. Swanson LW, Sawchenko PE, Rivier J, Vale WW. Organization of ovine corticotropin-releasing factor immunoreactive cells and fibres in the rat brain: Immunohistochemical study. Neuroendocrinology 1983; 36: 165-186.
5. Kozicz T, Yanaihara H, Arimura A. Distribution of urocortin-like immunoreactivity in the central nervous system of the rat. J Comp Neurol 1998; 391: 1-10.
6. Morin SM, Ling N, Liu XJ, Kahl SD, Gehlert DR. Differential distribution of urocortin- and corticotropin-releasing factor-like immunoreactivities in the rat brain. Neuroscience 1999; 92: 281-291.
7. Reyes TM, Lewis K, Perrin MH, Kunitake KS, Vaughan J, Arias CA, Hogenesh JB, Gulyas J, Rivier J, Vale WW, Sawchenko PE. Urocortin II: A member of the corticotropin-releasing-factor (CRF) neuropeptide family that is selectively bound by type 2 CRF receptors. Proc Natl Acad Sci USA 2001; 98: 2843-2848.
8. Lewis K, Li C, Perrin MH, Blount A, Kunitake K, Donaldson C, Vaughan J, Reyes TM, Gulyas J, Fisher W, Bilezikjian L, Rivier J, Sawchenko PE, Vale WW. Identification of urocortin III, an additional member of the corticotropin-releasing factor (CRF) family with high affinity for the CRF2 receptor. Proc Natl Acad Sci USA 2001; 98: 7570-7575.
9. Turnbull AV, Rivier C. Corticotropin-releasing factor (CRF) and endocrine responses to stress: CRF receptors, binding protein, and related peptides. Proc Soc Exp Biol Med 1997; 215: 1-10.
10. Skelton KH, Owens MJ, Nemeroff CB. The neurobiology of urocortin. Regul Pept 2000; 93: 85-92.
11. Parkes DG, Weisinger RS, May CN. Cardiovascular actions of CRH and urocortin: An update. Peptides 2001; 22: 821-827.
12. Coste SC, Quintos RF, Stenzel-Poore MP. Corticotropin-releasing hormone-related peptides and receptors: Emergent regulators of cardiovascular adaptations to stress. Trends Cardiovasc Med 2002; 12: 176-182.
13. De Fanti BA, Martinez JA. Central urocortin activation of sympathetic-regulated energy metabolism in Wistar rats. Brain Res 2002; 930: 37-41.
14. Tsigos C, Chrousos GP. Hypothalamic-pituitary-adrenal axis, neuroendocrine factors and stress. J Psychos Res 2002; 53: 865-871.
15. Huang Y, Yao X, Lau C, Chan Y, Tsang S, Chan FL. Urocortin and cardiovascular protection. Acta Pharmacol Sin 2004; 25: 257-265.
16. Kozicz T, Korosi A, Korsman C, Tilburg-Ouwens DTWM, Groenink L, Veening JG, van der Gugten J, Roubos EW, Olivier B. Urocortin expression in the Edinger-Westphal nucleus is down-regulated in transgenic mice over-expressing neuronal corticotropin-releasing factor. Neuroscience 2004; 123: 589-594.
17. Korosi A, Schotanus S, Olivier B, Roubos EW, Kozicz T. Chronic ether stress-induced response of urocortin 1 neurons in the Edinger-Westphal nucleus in the mouse. Brain Res 2005; 1046: 172-179.
18. Suda T, Kageyama K, Sakihara S, Nigawara T. Physiological roles of urocortins, human homologues of fish urotensin I, and their receptors. Peptides 2004; 25: 1689-1701.
19. Chen R, Lewis KA, Perrin MH, Vale WW. Expression cloning of a human corticotropin-releasing-factor receptor. Proc Natl Acad Sci USA 1993; 90: 8967-8971.
20. Perrin MH, Vale WW. Corticotropin releasing factor receptors and their ligand family. Ann NY Acad Sci 1999; 885: 312-328.
21. Potter E, Sutton S, Donaldson C, Chen R, Perrin M, Lewis K, Sawchenko PE, Vale WW. Distribution of corticotropin-releasing factor receptor mRNA expression in the rat brain and pituitary. Proc Natl Acad Sci USA 1994; 91: 8777-8781.
22. De Souza EB. Corticotropin-releasing factor receptors: Physiology, pharmacology, biochemistry and role in central nervous system and immune disorders. Psychoneuroendocrinology 1995; 20: 789-819.
23. Van Pett K, Viau V, Bittencourt JC, Chan RK, Li HY, Arias C, Prins GS, Perrin M, Vale WW, Sawchenko PE. Distribution of mRNAs encoding CRF receptors in brain and pituitary of rat and mouse. J Comp Neurol 2000; 428: 191-212.
24. Korosi A, Veening JG, Kozicz T, Henkens M, Dederen J, Groenink L, van der Gugten J, Olivier B, Roubos EW. Distribution and expression of CRF receptor 1 and 2 mRNAs in the CRF over-expressing mouse brain. Brain Res 2006; 1072: 46-54.
25. Stenzel-Poore MP, Heldwein KA, Stenzel P, Lee S, Vale WW. Characterization of the genomic corticotropin-releasing factor (CRF) gene from Xenopus laevis: Two members of the CRF family exist in amphibians. Mol Endocrinol 1992; 6: 1716-1724.
26. Boorse GC, Crespi EJ, Dautzenberg FM, Denver RJ. Urocortins of the South African clawed frog, Xenopus laevis: Conservation of structure and function in tetrapod evolution. Endocrinology 2005; 146: 4851-4860.
27. Yao M, Westphal NJ, Denver RJ. Distribution and acute stressor-induced activation of corticotrophin-releasing hormone neurones in the central nervous system of Xenopus laevis. J Neuroendocrinol 2004; 16: 880-893.
28. Calle M, Corstens GJ, Wang L, Kozicz T, Denver RJ, Barendregt HP, Roubos EW. Evidence that urocortin I acts as a neurohormone to stimulate alpha-MSH release in the toad Xenopus laevis. Brain Res 2005; 1040: 14-28.
29. Malagon MM, Ruiz-Navarro A, Torronteras R, Gracia-Navarro F. Effects of ovine CRF on amphibian pituitary ACTH and TSH cells in vivo: A quantitative ultrastructural study. Gen Comp Endocrinol 1991; 83: 487-497.
30. Ubink R, Jenks BG, Roubos EW. Physiologically induced Fos expression in the hypothalamo-hypophyseal system of Xenopus laevis. Neuroendocrinology 1997; 65: 413-422.
31. Boorse GC, Denver RJ. Expression and hypophysiotropic actions of corticotropin-releasing factor in Xenopus laevis. Gen Comp Endocrinol 2004; 137: 272-282.
32. Crespi EJ, Vaudry H, Denver RJ. Roles of corticotropin-releasing factor, neuropeptide Y and corticosterone in the regulation of food intake in Xenopus laevis. J Neuroendocrinol 2004; 16: 279-288.
33. Calle M, Kozicz T, van der Linden E, Desfeux A, Veening JG, Barendregt HP, Roubos EW. Effect of starvation on Fos and neuropeptide immunoreactivities in the brain and pituitary gland of Xenopus laevis. Gen Comp Endocrinol 2006; 147: 237-246.
34. Kramer BMR, Welting J, Berghs CAFM, Jenks BG, Roubos EW. Functional organization of the suprachiasmatic nucleus of Xenopus laevis in relation to background adaptation. J Comp Neurol 2001; 432: 346-355.
35. Kolk SM, Kramer BMR, Cornelisse LN, Scheenen WJJM, Jenks BG, Roubos EW. Multiple control and dynamic response of the Xenopus melanotrope cell. Comp Biochem Physiol B Biochem Mol Biol 2002; 132: 257-268.
36. Dotman CH, Maia A, Jenks BG, Roubos EW. Sauvagine and TRH differentially stimulate proopiomelanocortin biosynthesis in the Xenopus laevis intermediate pituitary. Neuroendocrinology 1997; 66: 106-113.
37. Verburg-van Kemenade BML, Jenks BG, Cruijsen PMJM, Dings A, Tonon MC, Vaudry H. Regulation of MSH release from the neurointermediate lobe of Xenopus laevis by CRF-like peptides. Peptides 1987; 8: 1093-1100.
38. Dautzenberg FM, Dietrich K, Palchaudhuri MR, Spiess J. Identification of two corticotropin-releasing factor receptors from Xenopus laevis with high ligand selectivity: Unusual pharmacology of the type 1 receptor. J Neurochem 1997; 69: 1640-1649.
39. Dautzenberg FM, Wille S, Lohmann R, Spiess J. Mapping of the ligand-selective domain of the Xenopus laevis corticotropin-releasing factor receptor 1: Implications for the ligand-binding site. Proc Natl Acad Sci USA 1998; 95: 4941-4946.
40. Dautzenberg FM, Py-Lang G, Higelin J, Fischer C, Wright MB, Huber G. Different binding modes of amphibian corticotropin-releasing factor 1 and 2 receptors: Evidence for evolutionary differences. J Pharmacol Exp Ther 2001; 296: 113-120.
41. Boorse GC, Denver RJ. Widespread tissue distribution and diverse functions of corticotropin-releasing factor and related peptides. Gen Comp Endocrinol 2006; 146: 9-18.
42. Altschul SF, Madden TL, Schaffer AA, Zhang J, Zhang Z, Miller W, Lipman DJ. Gapped BLAST and PSI-BLAST: A new generation of protein database search programs. Nucl Acid Res 1997; 25: 3389-3402.
43. Bliss CJ. Statistics in Biology. New York, NY: McGraw-Hill, Inc., 1967.
44. Shapiro HH, Wilk MB. An analysis of variance test for normality. Biometrika 1965; 52: 591-611.
45. Rijk EPCT, Jenks BG, Wendelaar Bonga SE. Morphology of the pars intermedia and the melanophore-stimulating cells in Xenopus laevis in relation to background adaptation. Gen Comp Endocrinol 1990; 79: 74-82.
46. Corstens GJH, Roubos EW, Jenks BG, van Erp PEJ. Analysis of Xenopus melanotrope cell size and POMC gene expression. Ann NY Acad Sci 2005; 1040: 269-272.
47. Bidaud I, Galas L, Bulant M, Jenks BG, Ouwens DTWM, Jégou S, Ladram A, Roubos EW, Tonon MC, Nicolas P, Vaudry H. Distribution of the mRNAs encoding the thyrotropin-releasing hormone (TRH) precursor and three TRH receptors in the brain and pituitary of Xenopus laevis: Effect of background colour adaptation on TRH and TRH receptor gene expression. J Comp Neurol 2004; 477: 11-28.
48. Jenks BG, Ouwens DTWM, Coolen MW, Roubos EW, Martens GJM. Demonstration of postsynaptic receptor plasticity in an amphibian neuroendocrine interface. J Neuroendocrinol 2002; 14: 843-845.
49. Verburg van Kemenade BML, Jenks BG, Visser TJ, Tonon MC, Vaudry H. Assessment of TRH as a potential MSH release stimulating factor in Xenopus laevis. Peptides 1987; 8: 69-76.
50. 2+ oscillations, cyclic AMP, and secretion in melanotrope cells of Xenopus laevis via Y1 receptor. Peptides 1995; 16: 889-895.